. Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann N Y Acad Sci. 2005 Jun;1052:116-35. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

Webinars

  1. Not Dead Yet: Estrogen Deserves Another Chance